Signaling and functions of angiopoietin-1 in vascular protection.

Circulation Research
Nicholas P J BrindleKari Alitalo

Abstract

Angiopoietin-1 (Ang1) has powerful vascular protective effects: suppressing plasma leakage, inhibiting vascular inflammation, and preventing endothelial death. Preclinical studies indicate that Ang1 may be therapeutically useful in a number of situations, including treatment of edema, endotoxemia, and transplant arteriosclerosis. However, the ligand has also been implicated in vessel remodeling, induction of angiogenesis and pulmonary hypertension, indicating that strategies to minimize any deleterious effects while optimizing vessel protection are likely to be needed. This review surveys the published data on vascular protective effects of Ang1 and highlights the therapeutic potential of this ligand, as well as possible limitations to its use. We also consider the data on Ang1 receptors and speculate on how to maximize therapeutic benefit by targeting the Tie receptors.

References

Nov 15, 1986·Lancet·C G Persson
Mar 12, 1993·Cell·Z SongyangR J Lechleider
Oct 7, 1997·Circulation Research·A L WongK G Peters
May 20, 1998·Current Biology : CB·T I KoblizekW Risau
Oct 17, 1998·Science·C SuriG D Yancopoulos
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D M ValenzuelaG D Yancopoulos
Mar 29, 2000·The Journal of Biological Chemistry·A PapapetropoulosW C Sessa
Mar 31, 2000·Nature Medicine·G ThurstonG D Yancopoulos
Sep 21, 2000·The Journal of Biological Chemistry·M B MarronN P Brindle
May 11, 2001·The Journal of Biological Chemistry·T R CarlsonA O Morla
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Injune KimGou Young Koh
Feb 5, 2002·Angiogenesis·M J HansburyJ D Winkler
Feb 28, 2002·Molecular and Cellular Biology·Christopher D KontosKevin G Peters
Feb 28, 2002·Microvascular Research·Achilleas C TsiamisNicholas P J Brindle
May 10, 2002·The American Journal of Pathology·Antonia M JoussenAnthony P Adamis
Jun 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Injune KimGou Young Koh
Jun 21, 2002·Microvascular Research·Rania HarfoucheSabah N A Hussain
Jul 13, 2002·Journal of Cellular Physiology·Sean F HackettPeter A Campochiaro

❮ Previous
Next ❯

Citations

Jun 3, 2008·Intensive Care Medicine·John S GiulianoDerek S Wheeler
Jun 30, 2012·Clinical and Experimental Medicine·Kunpeng WangWenfei Tan
Dec 10, 2013·Bulletin of Experimental Biology and Medicine·O I StepanovaS A Sel'kov
Jul 11, 2007·In Vitro Cellular & Developmental Biology. Animal·Su-Jeong HwangGyun Min Lee
Jan 30, 2010·In Vitro Cellular & Developmental Biology. Animal·Takaaki Fujii, Hiroyuki Kuwano
Oct 22, 2008·Oncogene·D A Cheresh, D G Stupack
Jul 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Elizabeth M ChislockAnn Marie Pendergast
Oct 10, 2013·The Journal of Biological Chemistry·Nicholas P J BrindleKathryn H Steele
Oct 30, 2013·Human Gene Therapy·Stephen M KaminskyRonald G Crystal
Oct 23, 2008·Tissue Engineering. Part a·Paul Van SlykeDan Dumont
Jul 6, 2010·European Heart Journal·Philipp KümpersMarius M Hoeper
Feb 25, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sascha DavidJan T Kielstein
Oct 7, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sascha DavidChristopher W McIntyre
Sep 22, 2007·Current Opinion in Lipidology·Frank D KolodgieRenu Virmani
Dec 20, 2007·Shock·John S GiulianoDerek S Wheeler
Mar 12, 2009·Molecular Cancer Research : MCR·Jeff H Tsai, William M F Lee
Jun 16, 2007·The Journal of Clinical Investigation·Yoshikazu NakaokaNaoki Mochizuki
Dec 20, 2012·Therapeutic Advances in Chronic Disease·Shahzad G Raja, Shahbaz M Raja
Oct 2, 2012·Critical Care : the Official Journal of the Critical Care Forum·Takeshi WadaHiroyuki Yokota
Oct 6, 2012·Critical Care : the Official Journal of the Critical Care Forum·Alessio AlfieriZoe L Brookes
May 14, 2009·Critical Care : the Official Journal of the Critical Care Forum·Matijs van MeursJan G Zijlstra
Aug 11, 2011·PloS One·Mahroo Mofarrahi, Sabah N A Hussain
Jan 27, 2012·PloS One·Paul A MonachPeter A Merkel
Jul 5, 2013·PloS One·Alexander LukaszOktay Tutarel
Nov 13, 2008·Journal of Cardiovascular Medicine·Ugo TestaGian Luigi Condorelli
Jan 25, 2013·International Journal of Molecular Sciences·Shan TianYongshan Hu
Mar 19, 2009·Experimental & Molecular Medicine·Shigetomo FukuharaNaoki Mochizuki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.